Market structure and drug innovation.
An explosion of knowledge and a growing array of tools and technologies have transformed modern drug R&D, while its cost has risen by a sizable amount. At the same time, the unchecked increase in health care and prescription drug spending has spawned cost containment policies that are restricting the demand for drugs in all major markets. This Perspective explores the interplay between technological advances and regulatory policies and their likely impact on the dynamics of the pharmaceutical industry.
Center for Economic Analysis of Competitiveness, Markets, and Regulation, University of Florence.
Fabio
F
Pammolli
Massimo
M
Riccaboni
D003363:Cost Control; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D019981:Health Care Sector; D012106:Research / Q000191:economics; D014481:United States